Overexpression of SET has been demonstrated in head and neck squamous cell carcinoma (HNSCC) and promotes HNSCC cell survival, proliferation and resistance to cell death by cisplatin in vivo.12, 13. This evidence concerns the gene SET and head and neck squamous cell carcinoma.